title: [Hypertension and diabetes: target blood pressure and blood pressure lowering by new antidiabetic drugs].
authors.affiliation: 1Center for Cardiovascular Research (CCR), Institut für Pharmakologie, Charité - Universitätsmedizin Berlin.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Kintscher
authors.affiliation: 2Praxis für Prävention und Therapie, Villingen-Schwenningen.
authors.forename: S
authors.initials: S
authors.lastname: Jacob
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003431:Cross-Cultural Comparison; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives; D019983:Guideline Adherence; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D052216:Glucagon-Like Peptide 1